NEW YORK, July 12, 2024 /PRNewswire/ -- The global central nervous system (CNS) stimulant drugs market size is estimated to grow by USD 6.48 billion from 2023-2027, according to Technavio. The market ...
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Ironshore Pharmaceuticals Inc. (“Ironshore”), a wholly owned subsidiary of Highland Therapeutics Inc. and a leader in the commercialization of novel ...
The FDA is updating warnings for stimulants prescribed for attention-deficit/hyperactivity disorder (ADHD) and other conditions, citing concerns about nonmedical use ...
A new report from researchers at the Ontario Drug Policy Research Network and Public Health Ontario shows the number of accidental drug and alcohol toxicity-related deaths continued to rise ...
Prescribing of central nervous system (CNS) stimulants and drugs used for attention deficit hyperactivity disorder (ADHD) has increased by almost two-thirds since 2015, according to calculations based ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. None of the combinations of stimulants and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results